MedTrace Logo

Lifetime Endurance Exercise to Prevent Coronary Artery Disease

NCT03711539 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1800

Last updated 2024-07-03

No results posted yet for this study

Summary

The primary objective of the Master@Heart Trial is to investigate whether lifelong endurance exercise reduces the incidence of non-calcified plaques (both mixed and soft plaques) as compared to late-onset endurance exercise and a non-athletic lifestyle.

Conditions

Sponsors & Collaborators

  • University Hospital, Antwerp

    collaborator OTHER

  • Jessa Hospital

    collaborator OTHER

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Eligibility

Min Age
45 Years
Max Age
70 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-10-18
Primary Completion
2021-10-01
Completion
2025-10-01

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03711539 on ClinicalTrials.gov